SYNERGY™ XD H7493941808220Recalls & reported problems
Boston Scientific Corporation · Everolimus-Eluting Platinum Chromium Coronary Stent System · Class 3 · Implant
All models of SYNERGY XD (65)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 7
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 08714729980704), received between May 26, 2021 and Feb 10, 2026 — classified as 1 injury, 6 malfunctions.
The most frequently reported specific device problem is “Break” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Break3
- Device Dislodged or Dislocated2
- Difficult to Advance2
- Material Deformation2
- Difficult to Remove1
- Failure to Advance1
- Material Separation1
- Nonstandard Device1
Patient problems
- No Clinical Signs, Symptoms or Conditions7
Recent adverse event reports
The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.
MalfunctionFeb 10, 2026Nonstandard Device; Material Separation
IT WAS REPORTED THAT MATERIAL SEPARATION OCCURRED. A 2.25 X 8MM SYNERGY XD DRUG-ELUTING STENT WAS SELECTED FOR TREATMENT; HOWEVER, A STENT DETACHMENT OCCURRED. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24309968 ↗MalfunctionAug 29, 2025Failure to Advance; Device Dislodged or Dislocated; Failure to Advance; Device Dislodged or Dislocated
IT WAS REPORTED THAT STENT DISLODGMENT OCCURRED. THE PATIENT PRESENTED WITH CORONARY ARTERY DISEASE AND UNDERWENT A PERCUTANEOUS CORONARY INTERVENTION. A 2.25 X 8MM SYNERGY? XD DRUG-ELUTING STENT WAS ADVANCED BUT FAILED TO CROSS THE LESION. UPON ATTEMPTED REMOVAL, THE STENT BECAME DISLODGED FROM THE DELIVERY SYSTEM AND WAS NO LONGER POSITIONED ON THE BALLOON. THE DISLODGED STENT WAS SUCCESSFULLY RETRIEVED ALONG WITH THE DELIVERY SYSTEM. THE PROCEDURE WAS COMPLETED USING A NEW STENT. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22927028 ↗MalfunctionJun 3, 2024Break; Break
IT WAS REPORTED THAT SHAFT BREAK OCCURRED. THE 80% STENOSED TARGET LESION WAS LOCATED IN THE MODERATELY TORTUOUS AND MILDLY CALCIFIED CIRCUMFLEX ARTERY. A 2.25 X 8MM SYNERGY XD DRUG-ELUTING STENT (DES) WAS OPENED OUT OF THE PACKAGE, BUT THE SHAFT WAS VISIBLY BROKEN AT PROXIMAL TO THE HUB. ANOTHER 2.25 X 8MM SYNERGY DES WAS OPENED AND ADVANCED BUT IT FAILED TO CROSS THE LESION. HOWEVER, WHEN THE PHYSICIAN ATTEMPTED TO TWIST THE STENT, IT DID NOT LOOK RIGHT, AND UPON REMOVAL FROM THE SHEATH, THE SHAFT WAS ALSO BROKEN AT PROXIMAL TO THE STENT BALLOON. THE PROCEDURE WAS COMPLETED WITH A NON-BOSTON SCIENTIFIC DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19445844 ↗MalfunctionDec 22, 2022Break; Difficult to Advance; Material Deformation; Break; Difficult to Advance; Material Deformation
IT WAS REPORTED THAT SHAFT BREAK OCCURRED. THE TARGET LESION WAS LOCATED IN THE SEVERELY TORTUOUS AND MILDLY CALCIFIED LEFT ANTERIOR DESCENDING ARTERY (LAD). A 2.25 X 8MM SYNERGY XD DRUG-ELUTING STENT (DES) WAS PREPARED TO BE DELIVERED. HOWEVER, THE SHAFT GOT KINKED OUTSIDE OF THE HEMOSTASIS VALVE. UPON CONTINUOUS ATTEMPT TO DELIVER THE DEVICE, THE PROXIMAL PORTION OF DELIVERY SHAFT BROKE OFF WHEN TRYING TO DELIVER AROUND THE HARD BEND. THE STENT AND REMAINING SHAFT WERE REMOVED WITH NO OTHER COMPLICATIONS. THE DETACHED PORTION WAS SIMPLY PULLED OUT AND THE PROCEDURE WAS COMPLETED WITH A NON-BOSTON SCIENTIFIC DEVICE. THERE WERE NO PATIENT COMPLICATIONS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16038234 ↗MalfunctionNov 14, 2022Break; Break
IT WAS REPORTED THAT SHAFT BREAK OCCURRED. THE PATIENT PRESENTED WITH CORONARY ARTERIAL DISEASE AND UNDERWENT PERCUTANEOUS CORONARY INTERVENTION. THE TARGET LESION WAS LOCATED IN THE MILDLY TORTUOUS AND MILDLY CALCIFIED LEFT CIRCUMFLEX ARTERY. A 2.25 X 8MM SYNERGY XD DRUG-ELUTING STENT WAS ADVANCED THROUGH A GUIDE CATHETER AND GUIDEZILLA GUIDE EXTENSION CATHETER. THE PHYSICIAN DECIDED TO REMOVE THE GUIDEZILLA TO MAKE THE STENT DELIVERY EASIER. HOWEVER, IT WAS NOTED THAT WHEN THE STENT WAS PULLED OUT OF THE BODY, THE SHAFT BROKE IN HALF. THE BROKEN SHAFT WAS PULLED OUT INTACT. A 2.50 X 8MM SYNERGY XD DRUG-ELUTING STENT WAS ADVANCED BUT FAILED TO CROSS THE LESION. UPON REMOVAL, IT WAS NOTED THAT THE STENT WAS FRAYED. ANOTHER 2.50 X 8MM SYNERGY XD DRUG-ELUTING STENT WAS USED TO COMPLETE THE PROCEDURE. NO PATIENT COMPLICATIONS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15788449 ↗InjuryAug 24, 2022Difficult to Remove; Device Dislodged or Dislocated; Difficult to Remove; Device Dislodged or Dislocated
IT WAS REPORTED THAT STENT DISLODGEMENT OCCURRED. THE TARGET LESION WAS LOCATED IN THE LEFT ANTERIOR DESCENDING ARTERY. A 2.25 X 8MM SYNERGY XD DRUG-ELUTING STENT WAS SELECTED FOR USE. HOWEVER, IT WAS NOTED THAT THE STENT DETACHED FROM THE DELIVERY SYSTEM. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF SAME DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT STATUS WAS STABLE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15287080 ↗MalfunctionMay 26, 2021Positioning Failure; Difficult to Advance; Material Deformation; Positioning Failure; Difficult to Advance; Material Deformation
IT WAS REPORTED THAT STENT DAMAGE OCCURRED. THE 100% STENOSED TARGET LESION WAS LOCATED IN THE MILDLY TORTUOUS AND MILDLY CALCIFIED DISTAL RIGHT CORONARY ARTERY. A 2.25 X 8MM SYNERGY XD DRUG-ELUTING STENT WAS ADVANCED BUT RESISTANCE WAS FELT AND COULD NOT INFLATE THE STENT. THE SHAFT WAS BENT DURING INSERTION. HOWEVER, UPON REMOVAL, THE STENT WAS CAUGHT AT THE EDGE WITH GUIDEZILLA GUIDE EXTENSION CATHETER AND WAS DEFORMED. THE DEVICE WAS REMOVED AND THE PROCEDURE WAS COMPLETED. THERE WERE NO PATIENT COMPLICATIONS NOR INJURIES REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11891376 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page